About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The main characteristic of our group is its multidisciplinary nature, as it is comprised of neuroradiologists, technologists, and a physicist, engineer, and biochemist.
The main objectives of our projects are to gain knowledge about the pathophysiologic mechanisms implicated in several neurological diseases and to evaluate new biomarkers and therapies through the use of qualitative and quantitative magnetic resonance (MR) and computed tomography (CT) techniques, and by applying artificial intelligence tools to create prognostic models. Our focus is on the study of diseases such as multiple sclerosis, epilepsy, neuro-oncology, and stroke.
In addition, because of the experience we have acquired along the years in performing MR studies, we act as a platform for designing MR-based projects, processing images, and conducting quantitative data analysis.
The purpose is to investigate the effects of psychiatric disorders on brain structure, integrity and function.
IP: Alex Rovira Cañellas
The objective of this research line is to evaluate the structural changes that occur in the brain after or during epileptic seizures using different MRI techniques, as well as assess the role of MRI in the etiological diagnosis and location of the epileptogenic focus and analyze its influence on the treatment and evolution of these patients.
IP: Silvana Isabel Sarria Estrada
The aim of the line is to evaluate the added value of the information provided by MRI techniques, mainly aimed at the evaluation of melanin, myelin, presence of Fe, structural and functional connectivity in the study of Parkinson’s disease.
IP: Fco. Javier Aymerich Martínez, Alex Rovira Cañellas
The objective of this research line is to evaluate the value of MRI in the diagnosis of autoimmune (NMOSD and MOGAD) diseases and as a marker of progression and treatment response.
IP: Cristina Auger Acosta, Alex Rovira Cañellas
IP: Deborah Pareto Onghena Collaborators: Jordi Rio Izquierdo, Elisenda Anglada Clofent, Juan Fco. Corral Gamez, Elena Huerga Núñez Funding agency: Instituto de Salud Carlos III Funding: 37510 Reference: PI18/00823 Duration: 01/01/2019 - 30/06/2023
IP: Jaume Sastre Garriga Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello, Cristina Auger Acosta, Alex Rovira Cañellas, Ana Zabalza de Torres, Joaquin Castillo Justribo Funding agency: Instituto de Salud Carlos III Funding: 96800 Reference: PI19/00950 Duration: 01/01/2020 - 30/06/2024
IP: Georgina Arrambide García Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Cristina Auger Acosta, Marta Rodríguez Barranco, Joaquin Castillo Justribo, Mireia Castillo Juarez Funding agency: Instituto de Salud Carlos III Funding: 110715 Reference: PI19/01590 Duration: 01/01/2020 - 30/06/2024
IP: Patricia Pozo Rosich Collaborators: Alicia Alpuente Ruiz, Juli Alonso Farre, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Edoardo Caronna Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI19/01684 Duration: 01/01/2020 - 30/06/2024
PMID: 37321841 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2023 Reference: J Neurol Neurosurg Psychiatry. 2023 Jun 15:jnnp-2023-331531. doi: 10.1136/jnnp-2023-331531. Impact factor: Publication type: Paper in international publication Authors: Alba-Arbalat, Salut; Barkhof, Frederik; Bellenberg, Barbara; Blanco, Yolanda; Calvi, Alberto; Ciccarelli, Olga; Collorone, Sara; Dineen, Robert A; Filippi, Massimo; Fleischer, Vinzenz et al. DOI: 10.1136/jnnp-2023-331531
PMID: 37336249 Journal: JOURNAL OF AFFECTIVE DISORDERS Year: 2023 Reference: J Affect Disord. 2023 Jun 17:S0165-0327(23)00799-1. doi: 10.1016/j.jad.2023.06.034. Impact factor: Publication type: Paper in international publication Authors: Alonso, Jordi; Amigo, Franco; Anmella, Gerard; Carreras, Bernat; De Prisco, Michele; Ferrer, Montse; Fico, Giovanna; Fortea, Adriana; Fortea, Lydia; Garcia-Mieres, Helena et al. DOI: 10.1016/j.jad.2023.06.034
PMID: 37396504 Journal: Genes & Diseases Year: 2023 Reference: Genes Dis. 2022 Jun 3;10(3):639-642. doi: 10.1016/j.gendis.2022.05.017. eCollection 2023 May. Impact factor: Publication type: Paper in international publication Authors: Aguilo, Silvia; Alonso, Judith; Ballester-Servera, Carme; Martinez-Gonzalez, Jose; Martinez-Martinez, Ernesto; Orriols, Mar; Puertas-Umbert, Lidia; Rodriguez, Cristina; Rodriguez-Sinovas, Antonio; Varona, Saray et al. DOI: 10.1016/j.gendis.2022.05.017
PMID: 37468284 Journal: NEUROLOGY Year: 2023 Reference: Neurology. 2023 Jul 19:10.1212/WNL.0000000000207664. doi: 10.1212/WNL.0000000000207664. Impact factor: Publication type: Paper in international publication Authors: Alvarez, Javier Villacieros; Arrambide, Georgina; Auger, Cristina; Carbonell-Mirabent, Pere; Castillo, Joaquin; Cobo-Calvo, Alvaro; Comabella, Manuel; Galan, Ingrid; Midaglia, Luciana Soledad; Mongay, Neus et al. DOI: 10.1212/WNL.0000000000207664
PMID: 35152335 Journal: JOURNAL OF NEUROLOGY Year: 2022 Reference: J Neurol. 2022 Jul;269(7):3761-3769. doi: 10.1007/s00415-022-11005-1. Epub 2022 Feb 13. Impact factor: 4.849 Publication type: Paper in international publication Authors: Coscojuela, P; Fonseca, E; Quintana, M; Sarria-Estrada, S; Santamarina, E; Abraira, L; Sueiras, M; Thonon, V; Alvarez-Sabin, J; Toledo, M et al. DOI: 10.1007/s00415-022-11005-1
PMID: 35747540 Journal: Neurology. Clinical practice Year: 2022 Reference: Neurol Clin Pract. 2022 Jun;12(3):263-269. doi: 10.1212/CPJ.0000000000001149. Impact factor: 0 Publication type: Paper in international publication Authors: Cohen, Jeffrey A; Weinshenker, Brian G; Rovira, Alex; Reich, Daniel S; Mowry, Ellen M; Makhani, Naila; Lublin, Fred D; Gaitan, Maria I; Cross, Anne H; Brownlee, Wallace et al. DOI: 10.1212/CPJ.0000000000001149
PMID: 35583667 Journal: NEURORADIOLOGY Year: 2022 Reference: Neuroradiology. 2022 May 18. pii: 10.1007/s00234-022-02973-2. doi: 10.1007/s00234-022-02973-2. Impact factor: 2.804 Publication type: Paper in international publication Authors: Aymerich, Francesc Xavier, Auger, Cristina, Alonso, Julio, Barros, Andrea, Clarke, Margareta A, Mora, Juan, Arrambide, Georgina, Corral, Juan Francisco, Andrino, Ana, Sastre-Garriga, Jaume et al. DOI: 10.1007/s00234-022-02973-2
PMID: 35364228 Journal: NEUROSCIENCE Year: 2022 Reference: Neuroscience. 2022 Jul 15;495:86-96. doi: 10.1016/j.neuroscience.2022.03.031. Epub 2022 Mar 29. Impact factor: 3.59 Publication type: Paper in international publication Authors: Frieske, Joana, Cuypers, Koen, Meesen, Raf L J, Alonso, Juli, Arevalo, Maria Jesus, Galan, Ingrid, Renom, Marta, Vidal-Jordana, Angela, Auger, Cristina, Montalban, Xavier et al. DOI: 10.1016/j.neuroscience.2022.03.031
Els doctors Xavier Montalban, Àlex Rovira i Mar Tintoré han estat reconeguts en la categoria de Neurociències i Comportament, i el doctor Jordi Rello en la categoria Interdisciplinària.
The program, promoted by Biocat in collaboration with CIMIT (Boston), is aimed at entrepreneurs in the process of bringing their technology to market in the next few years.
